Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global ...

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Inhalation And Nasal Spray Generic Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The ...

Investigators anticipate the results will help physicians tailor treatment methods for patients with chronic obstructive pulmonary disease (COPD) and help to better understand the demographic and ...

The FDA has accepted for review the supplemental New Drug Application for treprostinil inhalation solution for the treatment of IPF.

Leah J. Witt, MD: Hello. I'm Dr Leah Witt. Welcome to season one of Medscape InDiscussion, chronic obstructive pulmonary disease (COPD) podcast series. Today we're talking medications, especially ...

Inhaled therapeutics may help address antimicrobial resistance (AMR) by delivering medicines directly to the lungs, ...

Please provide your email address to receive an email when new articles are posted on . This analysis spanned from 2016 to 2022. Nearly 50% of patients were initially prescribed LABA/inhaled ...

Please provide your email address to receive an email when new articles are posted on . Even low-dose treatment courses of inhaled corticosteroids for asthma can lead to adrenal suppression including ...

Asthma is a condition where the airways constrict, leading to breathing difficulties. People with asthma may use inhalers to deliver medication to the airways to avoid asthma attacks or to relieve ...

Inhaled chronic obstructive pulmonary disease (COPD) medications prescribed before surgery in patients with early-stage non–small cell lung cancer (NSCLC) were associated with both short- and ...

Inhalers are the mainstay of treatment for asthma and chronic obstructive pulmonary disease (COPD). These products face limited generic competition in the US and remain expensive. To better understand ...

Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...